Carbetapentane Citrate

Spezifikationen

23142-01-0CAS-Nummer

245-449-5EG-Nummer

2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate;2-hydroxypropane-1,2,3-tricarboxylic acidIUPAC-Name

C26H39NO10Chemische Formel

525.6 g/molMolekulargewicht

Carbetapentane citrate; Pentoxyverine citrate; 23142-01-0; Loucarbate; Toclase; Toclase citrate; Pentoxyverine hydrogen citrate; 4SH0MFJ5HJ; NSC-757833; Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester) citrate; DTXSID10177717; 2-(2(Diethylamino)ethoxy)ethyl 1-phenyl-cyclopentanecarboxylate citrate (1:1); Cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester, citrate (1:1); RefChem:123517; DTXCID70100208; 2-(2-(Diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate monocitrate; 245-449-5; Pentoxiverine citrate; Carbetapentane (citrate); Carbetapentane citrate salt; MFCD00055697; Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester, 2-hydroxy-1,2,3-propanetricarboxylate (1:1); 2-(2-(Diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate citrate (1:1); 2-[2-(Diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate citrate; 1-Phenyl-cyclopentanecarboxylic acid 2-[2-(Diethylamino)ethoxy]ethyl ester citrate; Carbetapentone citrate; 1-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester citrate salt; SR-01000075435; EINECS 245-449-5; UNII-4SH0MFJ5HJ; Carbetapentane citrate [NF]; Astomatop (TN); C26H39NO10; Prestwick_748; Lopac-C-4662; 2-(2-(Diethylamino)ethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate dihydrogen citrate; MLS000859895; MLS002207180; SCHEMBL160096; SPECTRUM1501129; Pentoxyverine citrate (JP18); orb1225580; orb1310587; CHEMBL1256696; CHEBI:31352; HMS501B18; AKJDEXBCRLOVTH-UHFFFAOYSA-N; GLXC-08156; HMS1569M15; HMS1921H13; HMS2092F03; HMS2096M15; HMS2233B06; HMS3260P08; HMS3266A18; HMS3370A07; HMS3411M11; HMS3675M11; HMS3713M15; Pharmakon1600-01501129; CARBETAPENTANE CITRATE [MI]; PENTOXYVERINE CITRATE [JAN]; EX-A4861; HY-B1055; MSK10357; Tox21_500313; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate citrate; 2-(Diethylaminoethoxy)ethyl 1-Phenyl-1-cyclopentanecarboxylate Citrate; CCG-39029; NSC757833; CARBETAPENTANE CITRATE [VANDF]; PENTOXYVERINE CITRATE [MART.]; AKOS015899622; PENTOXYVERINE CITRATE [WHO-DD]; CS-4577; FP26824; LP00313; NSC 757833; NCGC00016128-01; NCGC00016128-02; NCGC00016128-03; NCGC00016128-04; NCGC00016128-05; NCGC00017090-01; NCGC00093760-01; NCGC00093760-02; NCGC00093760-03; NCGC00260998-01; AC-19682; AC-36723; AS-35372; BP166189; Diethyl(2-(2-((1-phenylcyclopentyl)formyloxy)ethoxy)ethyl)ammoniumdihydrogen 2-hydroxypropane-1,2,3-tricarboxylate; Pentoxyverine citrate - Bio-X trade mark; SY113110; CAS-23142-01-0; DB-046085; EU-0100313; C 4662; D01260; F792240; PENTOXYVERINE HYDROGEN CITRATE [EP MONOGRAPH]; SR-01000075435-1; SR-01000075435-3; SR-01000075435-5; SR-01000075435-7; SR-01000075435-8; Q27260431; SR-01000075435-11; 2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentane carboxylate citrate; citric acid;2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate; 1-Phenylcyclopentane-1-carboxylic acid diethylami noethoxyethyl ester citrate; 2-(2-(Diethylamino)Ethoxy)Ethyl 1-Phenylcyclopentane-1-Carboxylate 2-Hydroxypropane-1,2,3-Tricarboxylate; 2-Hydroxypropane-1,2,3-tricarboxylic acid--2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate (1/1)Synonyme